O2M TECHNOLOGIES, LLC

CHICAGO, IL

OncologyPhase I

What changed

Study registered, no phase assigned: Transcutaneous Electrical Acustimulation on Postoperative Bowel Function Recovery in Elderly Patients

2mo agoTrial registeredMay 15, 2026Source filing (opens the source filing in a new tab)

Momentum

79no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase I

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

950 pre-ticker oncology companies at Phase I

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
NA registered
Jun 1, 2026
Colorectal Cancer (CRC) · NOT_YET_RECRUITING · sponsor: Sir Run Run Shaw Hospital · Transcutaneous Electrical Acustimulation on Postoperative Bowel Function Recovery in Elderly Patients
ClinicalTrials.gov · NCT07574502 (opens the source filing in a new tab)
Grant
R44 · $1.2M · non-dilutive
Sep 19, 2025
O2M TECHNOLOGIES, LLC · PI KOTECHA, MRIGNAYANI · NCI · award ends Aug 31, 2027 · Advanced Imaging Methods in Pulse EPR
NIH RePORTER · NIH RePORTER 11182065 (opens the source filing in a new tab)
Grant
R21 · $428k · non-dilutive
Sep 1, 2025
UNIVERSITY OF WISCONSIN-MADISON · PI PAGEL, MARK DAVID · NIBIB · award ends Aug 31, 2027 · Evaluating hypoxia and vascular perfusion during pre-clinical wound healing using photoacoustic imaging
NIH RePORTER · NIH RePORTER 11214659 (opens the source filing in a new tab)
Trial
EARLY_PHASE1 registered
Jul 1, 2025
Schizophrenia, Avolition · NOT_YET_RECRUITING · sponsor: Peking University · A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia
ClinicalTrials.gov · NCT07011953 (opens the source filing in a new tab)
Grant
R01 · $652k · non-dilutive
Dec 1, 2022
CASE WESTERN RESERVE UNIVERSITY · PI FLASK, CHRISTOPHER A · NCI · award ends Nov 30, 2027 · Magnetic Resonance Fingerprinting of Tumor Vascular Perfusion and Acidosis
NIH RePORTER · NIH RePORTER 11224081 (opens the source filing in a new tab)
Grant
R01 · $693k · non-dilutive
Jul 1, 2022
CASE WESTERN RESERVE UNIVERSITY · PI YU, XIN · NINDS · award ends Mar 31, 2028 · AQP4 and glymphatic function in post-stroke recovery
NIH RePORTER · NIH RePORTER 11143274 (opens the source filing in a new tab)
Grant
R01 · $683k · non-dilutive
Aug 20, 2019
CLEVELAND CLINIC LERNER COM-CWRU · PI DELL, KATHERINE MACRAE · NIDDK · award ends Feb 28, 2029 · Imaging Assessments of ARPKD Kidney Disease Progression
NIH RePORTER · NIH RePORTER 11310770 (opens the source filing in a new tab)
Trial
Study registered
Jun 28, 2018
Functional Movement Disorder · COMPLETED · sponsor: The Cleveland Clinic · Mirror Box Therapy As a Treatment Option for Functional Movement Disorders
ClinicalTrials.gov · NCT03660098 (opens the source filing in a new tab)
Grant
P30 · $118k · non-dilutive
Aug 1, 1997
CASE WESTERN RESERVE UNIVERSITY · PI FLASK, CHRISTOPHER A · NCI · award ends Mar 31, 2030 · Imaging Research
NIH RePORTER · NIH RePORTER 11373652 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75principal investigator PAGEL, MARK DAVID is named on this company's filings
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
new_entity links the grant record at 0.38same therapeutic area

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Investigators

The principal investigators named on the grants below. Each links to their federal grant record and every other company traced to their work.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Study registered, no phase assigned: Transcutaneous Electrical Acustimulation on Postoperative Bowel Function Recovery in Elderly Patients
2mo agoTrial registeredSource (opens the source filing in a new tab)
NIH R01 · $0.7M · AQP4 and glymphatic function in post-stroke recovery
3mo agoGrant renewalSource (opens the source filing in a new tab)
NIH P30 · $0.1M · Imaging Research
3mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Imaging Assessments of ARPKD Kidney Disease Progression
5mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Magnetic Resonance Fingerprinting of Tumor Vascular Perfusion and Acidosis
7mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R44 · $1.2M · Advanced Imaging Methods in Pulse EPR
10mo agoNew grantSource (opens the source filing in a new tab)
NIH R21 · $0.4M · Evaluating hypoxia and vascular perfusion during pre-clinical wound healing using photoacoustic imaging
11mo agoNew grantSource (opens the source filing in a new tab)
Phase I trial registered: A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia
Jun 2025Trial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: Mirror Box Therapy As a Treatment Option for Functional Movement Disorders
Feb 2025Trial registeredSource (opens the source filing in a new tab)
Trial completed: Mirror Box Therapy As a Treatment Option for Functional Movement Disorders
Feb 2025Trial completedSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Peer position

Grant to raise

NA registered

R44 · $1.2M · non-dilutive

R21 · $428k · non-dilutive

EARLY_PHASE1 registered

R01 · $652k · non-dilutive

R01 · $693k · non-dilutive

R01 · $683k · non-dilutive

Study registered

P30 · $118k · non-dilutive